Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2014

01.12.2014

Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study

verfasst von: Sarah Zaman, Gopal Sivagangabalan, William Chik, Wayne Stafford, John Hayes, Russell Denman, Glenn Young, Prashanthan Sanders, Pramesh Kovoor

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In recent years, there has been a shift away from performing electrophysiologic study (EPS) to guide implantable cardioverter-defibrillator (ICD) implantation with a reliance on left ventricular ejection fraction (LVEF) alone.

Methods

ICD patients were prospectively recruited from the multicentre COMFORT (Concept of Optimal Management of ventricular Fibrillation Or Very fast ventricular Tachycardia) trial. Primary prevention ICD patients (n = 260, groups 1 and 2) were compared to secondary prevention ICD patients (n = 210, group 3). Primary prevention ICDs were implanted in patients with ischemic cardiomyopathy based on LVEF ≤ 40 % and inducible ventricular tachycardia (VT) at EPS (n = 123, group 1) or impaired LVEF alone (LVEF ≤ 30 % or LVEF ≤ 35 % with NYHA class II or III; n = 137, group 2). EPS was performed in 61 % of secondary prevention ICD patients (n = 129). Patients were followed up for >12 months with a primary endpoint of spontaneous VT/ventricular fibrillation (VF).

Results

A significantly higher rate of spontaneous VT/VF occurred in secondary versus primary prevention ICD patients (P < 0.001) and in EPS-guided versus LVEF-guided primary prevention ICD patients (P = 0.029). At 2 years, the proportion of patients with ≥1 VT/VF episode was 24.6 ± 4.2 %, 19.9 ± 4.6 % and 37.1 ± 3.9 % for groups 1, 2 and 3, respectively. In the secondary prevention, patients who underwent EPS, VT/VF occurred in 44.4 ± 5.9 % and 14.1 ± 6.6 % with a positive versus negative result, respectively (P = 0.02).

Conclusions

Secondary prevention ICD patients have more spontaneous VT/VF than primary prevention ICD patients. Secondary and primary prevention ICD patients with inducible VT at EPS have more VT/VF than patients without inducible VT or impaired LVEF alone.
Literatur
1.
Zurück zum Zitat Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–90.PubMedCrossRef Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–90.PubMedCrossRef
2.
Zurück zum Zitat Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New England Journal of Medicine, 335(26), 1933–40.PubMedCrossRef Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New England Journal of Medicine, 335(26), 1933–40.PubMedCrossRef
3.
Zurück zum Zitat Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346(12), 877–83.PubMedCrossRef Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346(12), 877–83.PubMedCrossRef
4.
Zurück zum Zitat Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–37.PubMedCrossRef Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–37.PubMedCrossRef
5.
Zurück zum Zitat Stockburger, M., Krebs, A., Nitardy, A., Habedank, D., Celebi, O., Knaus, T., et al. (2009). Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Pacing and Clinical Electrophysiology, 32(Suppl 1), S16–20.PubMedCrossRef Stockburger, M., Krebs, A., Nitardy, A., Habedank, D., Celebi, O., Knaus, T., et al. (2009). Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Pacing and Clinical Electrophysiology, 32(Suppl 1), S16–20.PubMedCrossRef
6.
Zurück zum Zitat Sweeney, M. O., Wathen, M. S., Volosin, K., Abdalla, I., DeGroot, P. J., Otterness, M. F., et al. (2005). Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation, 111(22), 2898–905.PubMedCrossRef Sweeney, M. O., Wathen, M. S., Volosin, K., Abdalla, I., DeGroot, P. J., Otterness, M. F., et al. (2005). Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation, 111(22), 2898–905.PubMedCrossRef
7.
Zurück zum Zitat van Welsenes, G. H., van Rees, J. B., Borleffs, C. J., Cannegieter, S. C., Bax, J. J., van Erven, L., et al. (2011). Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace, 13(3), 389–94.PubMedCrossRef van Welsenes, G. H., van Rees, J. B., Borleffs, C. J., Cannegieter, S. C., Bax, J. J., van Erven, L., et al. (2011). Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace, 13(3), 389–94.PubMedCrossRef
8.
Zurück zum Zitat Wilkoff, B. L., Hess, M., Young, J., & Abraham, W. T. (2004). Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. Journal of Cardiovascular Electrophysiology, 15(9), 1002–9.PubMedCrossRef Wilkoff, B. L., Hess, M., Young, J., & Abraham, W. T. (2004). Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. Journal of Cardiovascular Electrophysiology, 15(9), 1002–9.PubMedCrossRef
9.
Zurück zum Zitat Sivagangabalan, G., Chik, W., Zaman, S., Stafford, W., Hayes, J., Denman, R., et al. (2013). Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators. American Journal of Cardiology, 112(8), 1153–1157. Sivagangabalan, G., Chik, W., Zaman, S., Stafford, W., Hayes, J., Denman, R., et al. (2013). Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators. American Journal of Cardiology, 112(8), 1153–1157.
10.
Zurück zum Zitat Sivagangabalan, G., Eshoo, S., Eipper, V. E., Thiagalingam, A., & Kovoor, P. (2008). Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators. Pacing and Clinical Electrophysiology, 31(9), 1095–9.PubMedCrossRef Sivagangabalan, G., Eshoo, S., Eipper, V. E., Thiagalingam, A., & Kovoor, P. (2008). Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators. Pacing and Clinical Electrophysiology, 31(9), 1095–9.PubMedCrossRef
11.
Zurück zum Zitat Tokano, T., Bach, D., Chang, J., Davis, J., Souza, J. J., Zivin, A., et al. (1998). Effect of ventricular shock strength on cardiac haemodynamics. Journal of Cardiovascular Electrophysiology, 9, 791–797.PubMedCrossRef Tokano, T., Bach, D., Chang, J., Davis, J., Souza, J. J., Zivin, A., et al. (1998). Effect of ventricular shock strength on cardiac haemodynamics. Journal of Cardiovascular Electrophysiology, 9, 791–797.PubMedCrossRef
12.
Zurück zum Zitat Bourke, J. P., Richards, D. A., Ross, D. L., Wallace, E. M., McGuire, M. A., & Uther, J. B. (1991). Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. Journal of the American College of Cardiology, 18(3), 780–8.PubMedCrossRef Bourke, J. P., Richards, D. A., Ross, D. L., Wallace, E. M., McGuire, M. A., & Uther, J. B. (1991). Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. Journal of the American College of Cardiology, 18(3), 780–8.PubMedCrossRef
13.
Zurück zum Zitat Zaman, S., Sivagangabalan, G., Narayan, A., Thiagalingam, A., Ross, D. L., & Kovoor, P. (2009). Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation, 120(3), 194–200.PubMedCrossRef Zaman, S., Sivagangabalan, G., Narayan, A., Thiagalingam, A., Ross, D. L., & Kovoor, P. (2009). Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation, 120(3), 194–200.PubMedCrossRef
14.
Zurück zum Zitat Kumar, S., Sivagangabalan, G., Zaman, S., West, E. B., Narayan, A., Thiagalingam, A., et al. (2010). Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm, 7(11), 1589–97.PubMedCrossRef Kumar, S., Sivagangabalan, G., Zaman, S., West, E. B., Narayan, A., Thiagalingam, A., et al. (2010). Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm, 7(11), 1589–97.PubMedCrossRef
15.
Zurück zum Zitat Kumar, S., Sivagangabalan, G., Choi, M. C., Eipper, V., Thiagalingam, A., & Kovoor, P. (2010). Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200–250 ms) in patients with ischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology, 21(3), 262–9.PubMedCrossRef Kumar, S., Sivagangabalan, G., Choi, M. C., Eipper, V., Thiagalingam, A., & Kovoor, P. (2010). Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200–250 ms) in patients with ischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology, 21(3), 262–9.PubMedCrossRef
16.
Zurück zum Zitat Cheng, A., Wang, Y., Berger, R. D., Calkins, H., Buxton, A. E., Curtis, J. P., et al. (2012). Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR(R). Pacing and Clinical Electrophysiology, 35(8), 912–8.PubMedCrossRef Cheng, A., Wang, Y., Berger, R. D., Calkins, H., Buxton, A. E., Curtis, J. P., et al. (2012). Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR(R). Pacing and Clinical Electrophysiology, 35(8), 912–8.PubMedCrossRef
17.
Zurück zum Zitat Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., et al. (2007). Prophylactic catheter ablation for the prevention of defibrillator therapy. New England Journal of Medicine, 357(26), 2657–65.PubMedCentralPubMedCrossRef Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., et al. (2007). Prophylactic catheter ablation for the prevention of defibrillator therapy. New England Journal of Medicine, 357(26), 2657–65.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Daubert, J. P., Zareba, W., Hall, W. J., Schuger, C., Corsello, A., Leon, A. R., et al. (2006). Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of the American College of Cardiology, 47(1), 98–107.PubMedCrossRef Daubert, J. P., Zareba, W., Hall, W. J., Schuger, C., Corsello, A., Leon, A. R., et al. (2006). Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of the American College of Cardiology, 47(1), 98–107.PubMedCrossRef
19.
Zurück zum Zitat A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. New England Journal of Medicine. 1997 Nov 27;337(22):1576-83. PubMed PMID: 9411221. Epub 1997/12/31. eng. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. New England Journal of Medicine. 1997 Nov 27;337(22):1576-83. PubMed PMID: 9411221. Epub 1997/12/31. eng.
20.
Zurück zum Zitat Wilkoff, B. L., Williamson, B. D., Stern, R. S., Moore, S. L., Lu, F., Lee, S. W., et al. (2008). Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Journal of the American College of Cardiology, 52(7), 541–50.PubMedCrossRef Wilkoff, B. L., Williamson, B. D., Stern, R. S., Moore, S. L., Lu, F., Lee, S. W., et al. (2008). Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Journal of the American College of Cardiology, 52(7), 541–50.PubMedCrossRef
21.
Zurück zum Zitat Wathen, M. S., DeGroot, P. J., Sweeney, M. O., Stark, A. J., Otterness, M. F., Adkisson, W. O., et al. (2004). Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (Pain-FREE Rx II) trial results. Circulation, 110, 2591–2596.PubMedCrossRef Wathen, M. S., DeGroot, P. J., Sweeney, M. O., Stark, A. J., Otterness, M. F., Adkisson, W. O., et al. (2004). Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (Pain-FREE Rx II) trial results. Circulation, 110, 2591–2596.PubMedCrossRef
22.
Zurück zum Zitat Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., et al. (2002). Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation, 105, 589–594.PubMedCrossRef Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., et al. (2002). Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation, 105, 589–594.PubMedCrossRef
Metadaten
Titel
Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study
verfasst von
Sarah Zaman
Gopal Sivagangabalan
William Chik
Wayne Stafford
John Hayes
Russell Denman
Glenn Young
Prashanthan Sanders
Pramesh Kovoor
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2014
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-014-9941-8

Weitere Artikel der Ausgabe 3/2014

Journal of Interventional Cardiac Electrophysiology 3/2014 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.